Jan Geißler

2.7k total citations · 1 hit paper
48 papers, 786 citations indexed

About

Jan Geißler is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Jan Geißler has authored 48 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 14 papers in Public Health, Environmental and Occupational Health and 13 papers in General Health Professions. Recurrent topics in Jan Geißler's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Mental Health and Patient Involvement (10 papers). Jan Geißler is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Mental Health and Patient Involvement (10 papers). Jan Geißler collaborates with scholars based in United Kingdom, United States and Germany. Jan Geißler's co-authors include Mary Uhlenhopp, Bettina Ryll, Marc Boutin, Anton Hoos, Ify Sargeant, L Dewulf, Roslyn F. Schneider, Lotte Steuten, Joaquı́n Mateo and C. Benedikt Westphalen and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jan Geißler

38 papers receiving 765 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delivering precision oncology to patients with cancer

2022 197 citations Joaquı́n Mateo, Lotte Steuten et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Geißler United Kingdom	12	219	185	175	113	111	48	786
Festus Njuguna Kenya	20	98 0.4×	88 0.5×	375 2.1×	72 0.6×	82 0.7×	74	1.3k
Alice Chen United States	13	149 0.7×	151 0.8×	81 0.5×	54 0.5×	142 1.3×	45	950
Sasha Mazzarello Canada	22	101 0.5×	98 0.5×	150 0.9×	155 1.4×	26 0.2×	73	1.3k
Ateesha F. Mohamed United States	23	194 0.9×	540 2.9×	126 0.7×	57 0.5×	39 0.4×	66	1.3k
Claudio Jommi Italy	20	171 0.8×	684 3.7×	95 0.5×	70 0.6×	14 0.1×	106	1.2k
Anthony J. Hatswell United Kingdom	17	80 0.4×	338 1.8×	57 0.3×	26 0.2×	38 0.3×	65	826
Jill Kolesar United States	19	72 0.3×	33 0.2×	111 0.6×	146 1.3×	55 0.5×	68	948
Troy Budd United States	6	52 0.2×	96 0.5×	400 2.3×	127 1.1×	39 0.4×	10	926
Amy Law United States	18	133 0.6×	49 0.3×	365 2.1×	67 0.6×	84 0.8×	75	1.1k
Lisa M. Holle United States	16	61 0.3×	110 0.6×	133 0.8×	11 0.1×	80 0.7×	33	679

Countries citing papers authored by Jan Geißler

Since Specialization

Citations

This map shows the geographic impact of Jan Geißler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Geißler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Geißler more than expected).

Fields of papers citing papers by Jan Geißler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Geißler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Geißler. The network helps show where Jan Geißler may publish in the future.

Co-authorship network of co-authors of Jan Geißler

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Geißler. A scholar is included among the top collaborators of Jan Geißler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Geißler. Jan Geißler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rogers, Eamonn, Jan Geißler, Laura Dormer, et al.. (2025). Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: Project RISE. Future Oncology. 22(5). 515–524.

Ernst, Philipp, Christine M. Lohse, Michael Lauseker, et al.. (2025). Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective. Leukemia. 40(1). 29–36.

Tannock, Ian F., Madeline Pe, Christopher M. Booth, et al.. (2025). Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer. The Lancet Oncology. 26(9). e499–e507.

Kumar, Gayathri S., Amanda Cole, Lieven Annemans, et al.. (2024). Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens. The Oncologist. 29(6). 465–472.

Woolley, Karen L., Simon Stones, Richard Stephens, et al.. (2024). Patient authorship of medical research publications: An evolution, revolution, and solution?. Learned Publishing. 37(3). 5 indexed citations

Hughes, Timothy P., Giuseppe Saglio, Jan Geißler, et al.. (2024). Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE study. Journal of Hematology & Oncology. 17(1). 125–125. 4 indexed citations

Coutre, Philipp le, et al.. (2023). Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97). Frontiers in Oncology. 12. 1056786–1056786. 6 indexed citations

Blay, Jean‐Yves, Allan Hackshaw, Christophe Le Tourneau, et al.. (2023). 206P WAYFIND-R: A global, real-world database of patients (pts) with a solid tumour profiled with next-generation sequencing (NGS). Annals of Oncology. 34. S264–S265. 1 indexed citations

Geißler, Jan, et al.. (2023). Understanding Quality of Life in Patients With Acute Leukemia, a Global Survey. SHILAP Revista de lepidopterología. 10(1). 21–30. 5 indexed citations

10.

Gutiérrez‐Ibarluzea, Iñaki, et al.. (2023). Beyond Overall Survival: The Value of Oncology- Relevant Endpoints in HTA Body / Payer Decision-Making. 8(3).

11.

Hackshaw, Allan, Rodrigo Dienstmann, Jean‐Yves Blay, et al.. (2023). RWD12 Wayfind-R: A Global, Real-World Precision Oncology Registry – Socioeconomic Features. Value in Health. 26(12). S506–S506.

12.

Geißler, Jan, et al.. (2023). Delivering Digital Health Solutions that Patients Need: A Call to Action. Therapeutic Innovation & Regulatory Science. 58(2). 236–241. 3 indexed citations

13.

Geißler, Jan, et al.. (2023). Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare. European Journal of Cancer. 193. 113323–113323. 4 indexed citations

14.

Mateo, Joaquı́n, Lotte Steuten, Philippe Aftimos, et al.. (2022). Delivering precision oncology to patients with cancer. Nature Medicine. 28(4). 658–665. 197 indexed citations breakdown →

15.

Tourneau, Christophe Le, Allan Hackshaw, Jean‐Yves Blay, et al.. (2022). An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry. JCO Precision Oncology. 6(6). e2200019–e2200019. 8 indexed citations

16.

Geißler, Jan, et al.. (2022). Patient involvement in clinical trials. SHILAP Revista de lepidopterología. 2(1). 94–94. 20 indexed citations

17.

Harrison, Kathryn, Paula Williamson, Brian J.P. Huntly, et al.. (2020). Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting. Trials. 21(1). 437–437. 1 indexed citations

18.

Negrouk, Anastassia, et al.. (2020). Cross-Border Access to Clinical Trials in the EU: Exploratory Study on Needs and Reality. Frontiers in Medicine. 7. 585722–585722. 5 indexed citations

19.

Bombaci, Felice, et al.. (2020). Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs. Leukemia. 34(8). 2102–2112. 33 indexed citations

20.

Boutin, Marc, L Dewulf, Anton Hoos, et al.. (2016). Culture and Process Change as a Priority for Patient Engagement in Medicines Development. Therapeutic Innovation & Regulatory Science. 51(1). 29–38. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact